Liu Xu

484 total citations
17 papers, 381 citations indexed

About

Liu Xu is a scholar working on Cancer Research, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Liu Xu has authored 17 papers receiving a total of 381 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cancer Research, 5 papers in Molecular Biology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Liu Xu's work include Mycotoxins in Agriculture and Food (4 papers), MicroRNA in disease regulation (3 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). Liu Xu is often cited by papers focused on Mycotoxins in Agriculture and Food (4 papers), MicroRNA in disease regulation (3 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). Liu Xu collaborates with scholars based in China, United States and Ghana. Liu Xu's co-authors include Chenying Zeng, Junli Gong, Shi‐Mei Zhuang, Jian‐Hong Fang, Jing‐Ping Zhang, Lili Tang, David Ofori‐Adjei, Nii‐Ayi Ankrah, Henry J. Huebner and Evans Afriyie-Gyawu and has published in prestigious journals such as Oncogene, Bioconjugate Chemistry and IEEE Transactions on Instrumentation and Measurement.

In The Last Decade

Liu Xu

16 papers receiving 370 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liu Xu China 8 159 142 124 45 44 17 381
Prakash Baligar India 12 121 0.8× 209 1.5× 118 1.0× 29 0.6× 90 2.0× 32 647
Akmal A. El-Ghor Egypt 13 90 0.6× 106 0.7× 50 0.4× 23 0.5× 25 0.6× 25 497
Peipei Gao China 14 60 0.4× 188 1.3× 50 0.4× 52 1.2× 84 1.9× 42 526
Yajuan Cao China 13 51 0.3× 253 1.8× 166 1.3× 54 1.2× 61 1.4× 31 662
Ai‐min Leng China 11 96 0.6× 219 1.5× 90 0.7× 30 0.7× 81 1.8× 18 396
Xiaoxian Duan China 12 63 0.4× 182 1.3× 39 0.3× 34 0.8× 67 1.5× 24 479
Kejin Zhou China 11 85 0.5× 366 2.6× 306 2.5× 26 0.6× 36 0.8× 24 725
Remco Derr Netherlands 14 116 0.7× 148 1.0× 44 0.4× 28 0.6× 48 1.1× 20 479
Syed A. Aziz Canada 13 93 0.6× 82 0.6× 48 0.4× 50 1.1× 120 2.7× 33 450
Bingxin Lu China 10 54 0.3× 194 1.4× 40 0.3× 15 0.3× 56 1.3× 28 349

Countries citing papers authored by Liu Xu

Since Specialization
Citations

This map shows the geographic impact of Liu Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liu Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liu Xu more than expected).

Fields of papers citing papers by Liu Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liu Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liu Xu. The network helps show where Liu Xu may publish in the future.

Co-authorship network of co-authors of Liu Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Liu Xu. A scholar is included among the top collaborators of Liu Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liu Xu. Liu Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Liu, Zhongyan, et al.. (2025). Modified Evolutionary Aeromagnetic Compensation Method Considering Geomagnetic Variations. IEEE Transactions on Instrumentation and Measurement. 74. 1–8.
2.
Zhang, Yuqing, Chong‐De Lu, Liu Xu, et al.. (2023). Transarterial chemoembolization plus immune checkpoint inhibitor as postoperative adjuvant therapy for hepatocellular carcinoma with portal vein tumor thrombus: A multicenter cohort study. European Journal of Surgical Oncology. 49(7). 1226–1233. 5 indexed citations
3.
Wang, Qingqing, et al.. (2022). Primary hepatic neuroendocrine carcinoma with colon adenoma. International Journal of Surgery Case Reports. 95(C). 107176–107176. 1 indexed citations
4.
Jiang, Dawei, et al.. (2021). Low Serum miR‐607 Level as a Potential Diagnostic and Prognostic Biomarker in Patients of Pancreatic Ductal Adenocarcinoma: A Preliminary Study. Canadian Journal of Gastroenterology and Hepatology. 2021(1). 8882129–8882129. 10 indexed citations
5.
Pan, Weiwei, et al.. (2021). Prognostic Significance of Microvascular Invasion in Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-Analysis. Medical Science Monitor. 27. e930545–e930545. 2 indexed citations
6.
Xu, Liu, et al.. (2019). Gain of microRNA-103 triggers metastatic behavior by targeting ubiquitin specific peptidase 10 in pancreatic cancer.. PubMed. 12(4). 1214–1223. 4 indexed citations
7.
Shen, Lan, Liu Xu, Jie Zhang, & Dawei Jiang. (2018). Preoperative Serum Insulin-Like Growth Factor 1 Level as a Prognostic Factor in Patients Undergoing Hepatic Resection for Hepatocellular Carcinoma. Journal of Interferon & Cytokine Research. 38(4). 153–160. 3 indexed citations
8.
He, Hua, Shan Li, Xinjian Shi, et al.. (2018). Quantitative Nanoscopy of Small Blinking Graphene Nanocarriers in Drug Delivery. Bioconjugate Chemistry. 29(11). 3658–3666. 10 indexed citations
9.
Ji, Changwei, Ahu Yuan, Liu Xu, et al.. (2018). Activatable Photodynamic Therapy for Prostate Cancer by NIR Dye/Photosensitizer Loaded Albumin Nanoparticles. Journal of Biomedical Nanotechnology. 15(2). 311–318. 32 indexed citations
10.
Huang, Pintong, et al.. (2016). Pseudoenhancement of Gallbladder Sludge: A Confusing Artifact Caused by Nonlinear Propagation of Ultrasound Through Microbubbles. Ultraschall in der Medizin - European Journal of Ultrasound. 37(3). 307–309. 6 indexed citations
11.
Zhang, Jing‐Ping, Chenying Zeng, Liu Xu, et al.. (2013). MicroRNA-148a suppresses the epithelial–mesenchymal transition and metastasis of hepatoma cells by targeting Met/Snail signaling. Oncogene. 33(31). 4069–4076. 133 indexed citations
12.
Xu, Liu, et al.. (2011). [Establishment and characterization of serial subpopulations with highly metastatic potential via different metastatic routes].. PubMed. 91(26). 1852–5. 4 indexed citations
13.
Xu, Liu, Qi Cai, Lili Tang, et al.. (2010). Evaluation of fumonisin biomarkers in a cross-sectional study with two high-risk populations in China. Food Additives & Contaminants Part A. 27(8). 1161–1169. 38 indexed citations
14.
Tang, Lili, Liu Xu, Evans Afriyie-Gyawu, et al.. (2009). Aflatoxin–albumin adducts and correlation with decreased serum levels of vitamins A and E in an adult Ghanaian population. Food Additives & Contaminants Part A. 26(1). 108–118. 31 indexed citations
15.
Afriyie-Gyawu, Evans, Z. Wang, Nii‐Ayi Ankrah, et al.. (2008). NovaSil clay does not affect the concentrations of vitamins A and E and nutrient minerals in serum samples from Ghanaians at high risk for aflatoxicosis. Food Additives & Contaminants Part A. 25(7). 872–884. 41 indexed citations
16.
Afriyie-Gyawu, Evans, Nii‐Ayi Ankrah, Henry J. Huebner, et al.. (2007). NovaSil clay intervention in Ghanaians at high risk for aflatoxicosis. I. Study design and clinical outcomes. Food Additives & Contaminants Part A. 25(1). 76–87. 59 indexed citations
17.
Zhang, Yaojun, et al.. (2007). [Experience of radiofrequency ablation on liver malignancies: a report of 803 cases].. PubMed. 45(21). 1469–71. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026